Bio-Techne (TECH) Q1 CY2025 Highlights: Revenue: $316.2 million vs analyst estimates of $317.4 million (4.2% year-on-year growth, in line) Adjusted EPS: $0.56 vs analyst estimates of $0.51 (10.4% ...

Shares of Q32 Bio (QTTB) plummeted over 60% in premarket trading Wednesday following mixed results from Phase 2a trials of its lead candidate, bempikibart (ADX-914). The clinical-stage biotech ...

And much more. GIS Office Hours Steve Melly, GIS Analyst for Drexel's Urban Health Collaborative, is available for GIS support by appointment. To schedule an appointment for consulting services online ...